Forum for Science, Industry and Business
Sponsored by:     Siemens  n-tv 
Search our Site:

Topic (optional):

 

Home Reports Life Sciences Content

Microbiotic technology developed for microinjection of zebrafish embryos

next article
12.09.2007

Funded by an NSERC Idea to Innovations grant and an Ontario Early Researcher Award, Prof. Yu Sun’s group, the Advanced Micro and Nanosystems Laboratory (http://amnl.mie.utoronto.ca) at the University of Toronto (U of T) recently developed a microrobotic technology for automated microinjection of zebrafish embryos.

 

Based on computer vision and motion control, the automated microrobotic system is capable of immobilizing a large number of zebrafish embryos into a regular pattern within seconds and injecting 15 embryos (chorion unremoved) per minute with a success rate, survival rate, and phenotypic rate all close to 100%. The system and performance were reported in the journal PLoS ONE in an article entitled, “A Fully Automated Robotic System for Microinjection of Zebrafish Embryos.”


...more about:
developed embryos Technology zebrafish

Zebrafish is a model organism widely used in life sciences. High-speed injection of zebrafish embryos is important for screening genes in genetics and drug molecules in drug discovery. The automated microrobotic system proves itself as a reliable tool for determining gene functions and more generally, for facilitating large-scale molecule screening.

The technology was licensed to Marksman Cellject Inc. (http://www.marksman-cellject.com) for commercialization. Marksman Cellject Inc. is a start-up biotechnology company created by The Innovations Group (TIG) (http://www.innovations.utoronto.ca).

Collaborating with the Toronto Centre for Advanced Reproductive Technology, a fertility clinic (http://www.tcartonline.com), Marksman Cellject Inc. has received an Ontario Centres of Excellence grant to extend the zebrafish injection technology to mouse/human oocyte/embryo injection for in-vitro fertilization applications.

TIG is part of the Office of Research at U of T with the mandate of commercializing discoveries developed by its researchers and healthcare partners in the areas of Physical Sciences, Information Technology and Life Science for society’s benefit. Among TIG’s other recent start-ups are Greencore Composites (http://www.greencorenfc.com), Cast Connex (http://www.castconnex.com), Opalux (http://www.opalux.com), and Sketch2 (press release - http://www.theglobeandmail.com/servlet/story/LAC.20070515.SRINNO15/TPStory/?query=innovation).

Andrew Hyde | Source: alphagalileo
Further information: www.plosone.org
www.plosone.org/doi/pone.0000862

Further Reports about: developed embryos Technology zebrafish

next article

More articles from Life Sciences:

nachricht First reconstitution of an epidermis from human embryonic stem cells
23.11.2009 | INSERM (Institut national de la santé et de la recherche médicale)

nachricht Causative gene of a rare disorder discovered by sequencing only protein-coding regions of genome
23.11.2009 | University of Washington

All articles from Life Sciences >>>

B2B Search

Product / Service
Company / Organisation

Latest News

UCSB physicists move 1 step closer to quantum computing

23.11.2009 | Physics and Astronomy

Fat around the middle increases the risk of dementia

23.11.2009 | Studies and Analyses

New discovery about the formation of new brain cells

23.11.2009 | Health and Medicine

VideoLinks

Event News

Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients

20.11.2009 | Event News

'Golden Age' for clinical psychology in Northern Ireland

20.11.2009 | Event News

New Perspectives in Marine Anti-Fouling Research

11.11.2009 | Event News